-
Featured Authors
Archive
- May 2013 (2)
- April 2013 (5)
- March 2013 (2)
- February 2013 (4)
- January 2013 (1)
- December 2012 (2)
- November 2012 (3)
- October 2012 (3)
- September 2012 (3)
- August 2012 (5)
- July 2012 (4)
- June 2012 (7)
- May 2012 (5)
- April 2012 (3)
- March 2012 (4)
- February 2012 (6)
- January 2012 (2)
- December 2011 (2)
- November 2011 (3)
- October 2011 (3)
- September 2011 (5)
- August 2011 (4)
- July 2011 (8)
- June 2011 (16)
- May 2011 (8)
- April 2011 (9)
- March 2011 (14)
- February 2011 (9)
- January 2011 (15)
- December 2010 (7)
- November 2010 (6)
- October 2010 (4)
- June 2010 (1)
- May 2010 (4)
- April 2010 (14)
- March 2010 (4)
- January 2010 (5)
- November 2009 (3)
- October 2009 (1)
- August 2009 (6)
- July 2009 (9)
- June 2009 (9)
- May 2009 (8)
- April 2009 (9)
- March 2009 (9)
- February 2009 (3)
- January 2009 (1)
- November 2008 (1)
Category Archives: Patently BIOtech
Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review
We are receiving reports from Brazil that the Brazilian Attorney General of the Union (AGU) has adopted a position restricting the role of the National Agency for Sanitary Surveillance (ANVISA) in the patenting process for pharmaceutical products and processes. Due to a lack of clarity in the Industrial Property Law, ANVISA has used its prior consent role to reject patent applications on the basis of novelty and inventiveness which is officially the role of the Read More >
BIO Press Release: Former British Prime Minister Tony Blair to Present a Keynote Address at 2011 BIO International Convention
Former British Prime Minister Tony Blair to Present a Keynote Address at 2011 BIO International Convention Convention to take place June 27-30, 2011 in Washington, DC WASHINGTON, D.C. – (January 31, 2011) – The Biotechnology Industry Organization (BIO) announced today that former British Prime Minister Tony Blair will participate in a keynote presentation at the 2011 BIO International Convention. BIO President and CEO Jim Greenwood will host an “Interview with Tony Blair” during Read More >
BIO Supports Patent Reform Act of 2011: Press Release
BIO Supports Patent Reform Act of 2011 Bipartisan, consensus-oriented approach will strengthen nation’s patent system Washington, D.C. (January 28, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following comment on the introduction of the Patent Reform Act of 2011 (S. 23) by Senate Judiciary Committee Chairman Patrick Leahy (D-VT) earlier this week: “BIO appreciates the dedication of Chairman Leahy, Ranking Member Charles Grassley (R-IA) and the bill’s other cosponsors for their Read More >
Biotechnology and the State of the Union Address
The following was published in Politico’s Join the Debate. Politico asked “What should Obama say in the State of the Union?” Jim Greenwood Former Congressman (R-Pa.), President and CEO, Biotechnology Industry Organization : The president’s State of the Union should, rightly, focus on jobs, particularly the need to create and fill new jobs to compete in an increasing competitive global marketplace. There’s no industry that better exemplifies the promise of job creation than Read More >
PTO Director Kappos Remarks at Innovation Alliance Conference: IP leads to job growth
Thank you Roger [Martin], for that kind introduction. I would like to thank the Innovation Alliance for having me in today to speak with you about intellectual property’s vital role in today’s innovation economy. America stands at a critical juncture in our economic evolution, and intellectual property will play a key role in driving our economic growth and renewal. As technological advances bring great change to the speed and complexity of American innovation, strong intellectual Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: Axletech International, backlog reduction, Bayh-Dole, Chairman Leahy, Court of Appeals for the Federal Circuit, David Kappos, Department of Commerce, Director Kappos, economic development, economic growth, Green Technology, Harvard Business Review, Innovation Alliance, Intellectual Property, International, IP policy, job growth, Obama Administration, patent, Patent Reform, patents, PTO, Track 1, United States Patent and Trademark Office, USPTO, Xencor
Tags: Axletech International, backlog reduction, Bayh-Dole, Chairman Leahy, Court of Appeals for the Federal Circuit, David Kappos, Department of Commerce, Director Kappos, economic development, economic growth, Green Technology, Harvard Business Review, Innovation Alliance, Intellectual Property, International, IP policy, job growth, Obama Administration, patent, Patent Reform, patents, PTO, Track 1, United States Patent and Trademark Office, USPTO, Xencor





